Disorders of glucose metabolism, namely glucose intolerance and diabetes, are frequent in
patients with chronic liver diseases. In patients with cirrhosis, diabetes can be either a …

Hepatitis C virus (HCV) is a leading etiology of hepatocellular carcinoma (HCC). The
interaction of HCV with its human host is complex and multilayered; stemming in part from …

Background Data are scarce regarding the development of hepatic decompensation in
patients with non-alcoholic fatty liver disease (NAFLD) with and without type 2 diabetes. We …

Aim Sarcopenia impairs the outcome of patients with liver cirrhosis independently of liver
function reserves. The aim of this study was to investigate whether the rate of skeletal …

Insulin resistance (IR) is defined as a lower-than-expected response to insulin action from
target tissues, leading to the development of type 2 diabetes through the impairment of both …

AIM To summarise the literature data on hepatitis C virus (HCV)-infected patients concerning
the prevalence of glucose abnormalities and associated risk. METHODS We conducted a …

Hepatocellular carcinoma (HCC) is one of the most common malignancies leading to high
mortality rates in the general population; in cirrhotic patients, it is the primary cause of death …

The diagnosis of cirrhosis, especially in the advanced/decompensated stages, is made
using simple and inexpensive clinico-radiologicpathological techniques1. Qin et al. 2 …

By definition, hepatogenous diabetes is directly caused by loss of liver function, implying that
it develops after cirrhosis onset. Therefore, it should be distinguished from type 2 diabetes …

The fundamental understanding of liver disease, especially cirrhosis and its complications,
has changed dramatically over the last decade with the introduction of the culture …